title: [Pertuzumab. Dual strategy for the first-line treatment of metastatic HER2-positive breast cancer].
authors.affiliation: clbruhn@web.de
authors.forename: Claudia
authors.initials: C
authors.lastname: Bruhn
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D004347:Drug Interactions; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human; C485206:pertuzumab